Zhejiang Xianju Pharmaceutical Co., Ltd. announced its plan to purchase Directors' and Senior Management Liability Insurance to enhance risk management and protect the rights and interests of the company and its shareholders. The board of directors has approved the proposal, which will be submitted to the 2025 annual general meeting for shareholder approval. The insurance coverage will be up to RMB 100 million per year, with annual premiums not exceeding RMB 0.5 million for a 12-month term.
Summary generated by AI · Always verify with source document
Stock Code: 002332 Stock Abbreviation: Xianju Pharmaceutical Announcement No.: 2026-015
Zhejiang Xianju Pharmaceutical Co., Ltd. Announcement on Purchasing Directors' and Senior Management Liability Insurance
The Company and the entire Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.